235 related articles for article (PubMed ID: 30021061)
1. Longterm Risk of Solid Organ De Novo Malignancies After Liver Transplantation: A French National Study on 11,226 Patients.
Sérée O; Altieri M; Guillaume E; De Mil R; Lobbedez T; Robinson P; Segol P; Salamé E; Abergel A; Boillot O; Conti F; Chazouillères O; Debette-Gratien M; Debray D; Hery G; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Jacquemin E; Kamar N; Latournerie M; Lebray P; Leroy V; Mazzola A; Neau-Cransac M; Pageaux GP; Radenne S; Saliba F; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Launoy G; Dumortier J
Liver Transpl; 2018 Oct; 24(10):1425-1436. PubMed ID: 30021061
[TBL] [Abstract][Full Text] [Related]
2. Incidence and long-term risk of de novo malignancies after liver transplantation with implications for prevention and detection.
Schrem H; Kurok M; Kaltenborn A; Vogel A; Walter U; Zachau L; Manns MP; Klempnauer J; Kleine M
Liver Transpl; 2013 Nov; 19(11):1252-61. PubMed ID: 24106037
[TBL] [Abstract][Full Text] [Related]
3. Risk of virus and non-virus related malignancies following immunosuppression in a cohort of liver transplant recipients. Italy, 1985-2014.
Taborelli M; Piselli P; Ettorre GM; Lauro A; Galatioto L; Baccarani U; Rendina M; Shalaby S; Petrara R; Nudo F; Toti L; Sforza D; Fantola G; Cimaglia C; Agresta A; Vennarecci G; Pinna AD; Gruttadauria S; Risaliti A; Di Leo A; Burra P; Rossi M; Tisone G; Zamboni F; Serraino D;
Int J Cancer; 2018 Oct; 143(7):1588-1594. PubMed ID: 29693248
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors and Outcomes of De Novo Cancers (Excluding Nonmelanoma Skin Cancer) After Liver Transplantation for Primary Sclerosing Cholangitis.
Mouchli MA; Singh S; Loftus EV; Boardman L; Talwalkar J; Rosen CB; Heimbach JK; Wiesner RH; Hasan B; Poterucha JJ; Kymberly WD
Transplantation; 2017 Aug; 101(8):1859-1866. PubMed ID: 28272287
[TBL] [Abstract][Full Text] [Related]
5. De novo malignancy post-liver transplantation: a single center, population controlled study.
Chatrath H; Berman K; Vuppalanchi R; Slaven J; Kwo P; Tector AJ; Chalasani N; Ghabril M
Clin Transplant; 2013; 27(4):582-90. PubMed ID: 23808800
[TBL] [Abstract][Full Text] [Related]
6. Post-transplant malignancy in liver transplantation: a single center experience.
Hsiao CY; Lee PH; Ho CM; Wu YM; Ho MC; Hu RH
Medicine (Baltimore); 2014 Dec; 93(28):e310. PubMed ID: 25526480
[TBL] [Abstract][Full Text] [Related]
7. Comparison of de novo tumours after liver transplantation with incidence rates from Italian cancer registries.
Baccarani U; Piselli P; Serraino D; Adani GL; Lorenzin D; Gambato M; Buda A; Zanus G; Vitale A; De Paoli A; Cimaglia C; Bresadola V; Toniutto P; Risaliti A; Cillo U; Bresadola F; Burra P
Dig Liver Dis; 2010 Jan; 42(1):55-60. PubMed ID: 19497797
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressive regimen and risk for de novo malignancies after liver transplantation for alcoholic liver disease.
Dumortier J; Maucort-Boulch D; Poinsot D; Thimonier E; Chambon-Augoyard C; Ducroux E; Vallin M; Walter T; Robinson P; Guillaud O; Boillot O
Clin Res Hepatol Gastroenterol; 2018 Oct; 42(5):427-435. PubMed ID: 29861393
[TBL] [Abstract][Full Text] [Related]
9. Risk of malignant neoplasms after liver transplantation: a population-based study.
Aberg F; Pukkala E; Höckerstedt K; Sankila R; Isoniemi H
Liver Transpl; 2008 Oct; 14(10):1428-36. PubMed ID: 18825704
[TBL] [Abstract][Full Text] [Related]
10. De Novo Malignancies Screening After Liver Transplantation for Alcoholic Liver Disease: A Comparative Opportunistic Study.
Renaud L; Hilleret MN; Thimonier E; Guillaud O; Arbib F; Ferretti G; Jankowski A; Chambon-Augoyard C; Erard-Poinsot D; Decaens T; Boillot O; Leroy V; Dumortier J
Liver Transpl; 2018 Dec; 24(12):1690-1698. PubMed ID: 30207421
[TBL] [Abstract][Full Text] [Related]
11. The 28-year incidence of de novo malignancies after liver transplantation: A single-center analysis of risk factors and mortality in 1616 patients.
Rademacher S; Seehofer D; Eurich D; Schoening W; Neuhaus R; Oellinger R; Denecke T; Pascher A; Schott E; Sinn M; Neuhaus P; Pratschke J
Liver Transpl; 2017 Nov; 23(11):1404-1414. PubMed ID: 28590598
[TBL] [Abstract][Full Text] [Related]
12. Long-term probability of and mortality from de novo malignancy after liver transplantation.
Watt KD; Pedersen RA; Kremers WK; Heimbach JK; Sanchez W; Gores GJ
Gastroenterology; 2009 Dec; 137(6):2010-7. PubMed ID: 19766646
[TBL] [Abstract][Full Text] [Related]
13. Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients.
Altieri M; Sérée O; Lobbedez T; Segol P; Abergel A; Blaizot X; Boillot O; Boudjema K; Coilly A; Conti F; Chazouillères O; Debette-Gratien M; Dharancy S; Durand F; Duvoux C; Francoz C; Gugenheim J; Hardwigsen J; Houssel-Debry P; Kamar N; Latournerie M; Lebray P; Leroy V; Neau-Cransac M; Pageaux GP; Radenne S; Salamé E; Saliba F; Samuel D; Vanlemmens C; Besch C; Launoy G; Dumortier J
Clin Res Hepatol Gastroenterol; 2021 Jul; 45(4):101514. PubMed ID: 33714907
[TBL] [Abstract][Full Text] [Related]
14. National survey of de novo malignancy after solid organ transplantation in Japan.
Miyazaki T; Sato S; Kondo T; Kusaka M; Gotoh M; Saiki Y; Ono M; Kokudo N; Enosawa S; Satoh S; Soeda E; Furukawa H; Kobayashi E; Nagayasu T
Surg Today; 2018 Jun; 48(6):618-624. PubMed ID: 29380136
[TBL] [Abstract][Full Text] [Related]
15. Clinical Significance of De Novo Malignancy After Liver Transplant: A Single-Center Study.
Kim S; Rovgaliyev B; Lee JM; Lee KW; Hong SK; Cho JH; Yoon KC; Yi NJ; Suh KS
Transplant Proc; 2021; 53(1):200-206. PubMed ID: 32409224
[TBL] [Abstract][Full Text] [Related]
16. Liver transplantation and alcoholic liver disease: History, controversies, and considerations.
Marroni CA; Fleck AM; Fernandes SA; Galant LH; Mucenic M; de Mattos Meine MH; Mariante-Neto G; Brandão ABM
World J Gastroenterol; 2018 Jul; 24(26):2785-2805. PubMed ID: 30018475
[TBL] [Abstract][Full Text] [Related]
17. Review of Standardized Incidence Ratios (SIR) of non-lymphoid de novo malignancies after liver transplantation: Structured analysis of global differences.
Patel JA; Daoud D; Jain A
Transplant Rev (Orlando); 2022 Jan; 36(1):100670. PubMed ID: 34688986
[TBL] [Abstract][Full Text] [Related]
18.
Manzia TM; Angelico R; Gazia C; Lenci I; Milana M; Ademoyero OT; Pedini D; Toti L; Spada M; Tisone G; Baiocchi L
World J Gastroenterol; 2019 Sep; 25(35):5356-5375. PubMed ID: 31558879
[TBL] [Abstract][Full Text] [Related]
19. Conversion to everolimus dramatically improves the prognosis of de novo malignancies after liver transplantation for alcoholic liver disease.
Thimonier E; Guillaud O; Walter T; Decullier E; Vallin M; Boillot O; Dumortier J
Clin Transplant; 2014 Dec; 28(12):1339-48. PubMed ID: 25081431
[TBL] [Abstract][Full Text] [Related]
20. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]